To expand on the in vitro findings, a mouse sub‐renal graft model was employed to test whether FST KD could have an impact on tumour growth following implantation of PC3/WPMY‐1 cell recombinants (Fig. 8A). The gene discussed is FST; the disease is neoplasm.